Erin Wright
Stock Analyst at Morgan Stanley
(4.52)
# 330
Out of 4,745 analysts
208
Total ratings
65.79%
Success rate
14.18%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PDCO Patterson Companies | Maintains: Equal-Weight | $27 → $31 | $30.93 | +1.36% | 9 | Dec 17, 2024 | |
| MCK McKesson | Maintains: Overweight | $612 → $642 | $591.58 | +8.52% | 5 | Dec 17, 2024 | |
| PAHC Phibro Animal Health | Maintains: Equal-Weight | $20 → $25 | $21.91 | +14.10% | 21 | Dec 17, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Overweight | $30 → $23 | $19.53 | +17.77% | 12 | Dec 17, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $19 → $20 | $22.82 | -12.36% | 2 | Dec 17, 2024 | |
| HUM Humana | Maintains: Equal-Weight | $288 → $301 | $294.63 | +2.16% | 2 | Dec 17, 2024 | |
| CAH Cardinal Health | Maintains: Overweight | $127 → $136 | $128.83 | +5.57% | 8 | Dec 17, 2024 | |
| DGX Quest Diagnostics | Upgrades: Overweight | $145 → $172 | $155.28 | +10.77% | 5 | Dec 17, 2024 | |
| ALGN Align Technology | Maintains: Overweight | $310 → $280 | $233.30 | +20.02% | 20 | Oct 24, 2024 | |
| ELV Elevance Health | Maintains: Overweight | $643 → $551 | $400.96 | +37.42% | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $9 → $7 | $11.87 | -41.03% | 7 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $17 → $15 | $12.08 | +24.17% | 9 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6.5 → $3.5 | $4.94 | -29.15% | 11 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $620 → $596 | $435.33 | +36.91% | 11 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $33 → $21 | $21.45 | -2.10% | 6 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $382 → $392 | $293.64 | +33.50% | 3 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $69 → $65 | $74.97 | -13.30% | 4 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $54.55 | +83.32% | 4 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $532.51 | +10.23% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $264 → $248 | $168.61 | +47.08% | 5 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $246.00 | +21.95% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $22.06 | +90.39% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $245.80 | +17.17% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $164.97 | +113.37% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $5.62 | +682.92% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $344.07 | -47.39% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $97.50 | -82.56% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $39.27 | +208.12% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $574.82 | +0.90% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $13.26 | +163.95% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $200.48 | +2.25% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $17.21 | -36.08% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $204.33 | -23.16% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $38 | $22.39 | +69.72% | 1 | May 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $31 → $17 | $14.94 | +13.79% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $496.96 | -38.02% | 1 | Oct 25, 2017 |
Patterson Companies
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $27 → $31
Current: $30.93
Upside: +1.36%
McKesson
Dec 17, 2024
Maintains: Overweight
Price Target: $612 → $642
Current: $591.58
Upside: +8.52%
Phibro Animal Health
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $20 → $25
Current: $21.91
Upside: +14.10%
DENTSPLY SIRONA
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $19.53
Upside: +17.77%
BrightSpring Health Services
Dec 17, 2024
Maintains: Overweight
Price Target: $19 → $20
Current: $22.82
Upside: -12.36%
Humana
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $288 → $301
Current: $294.63
Upside: +2.16%
Cardinal Health
Dec 17, 2024
Maintains: Overweight
Price Target: $127 → $136
Current: $128.83
Upside: +5.57%
Quest Diagnostics
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $155.28
Upside: +10.77%
Align Technology
Oct 24, 2024
Maintains: Overweight
Price Target: $310 → $280
Current: $233.30
Upside: +20.02%
Elevance Health
Oct 23, 2024
Maintains: Overweight
Price Target: $643 → $551
Current: $400.96
Upside: +37.42%
Oct 11, 2024
Maintains: Underweight
Price Target: $9 → $7
Current: $11.87
Upside: -41.03%
Sep 19, 2024
Downgrades: Equal-Weight
Price Target: $17 → $15
Current: $12.08
Upside: +24.17%
Jun 12, 2024
Maintains: Underweight
Price Target: $6.5 → $3.5
Current: $4.94
Upside: -29.15%
May 14, 2024
Maintains: Overweight
Price Target: $620 → $596
Current: $435.33
Upside: +36.91%
Apr 26, 2024
Downgrades: Equal-Weight
Price Target: $33 → $21
Current: $21.45
Upside: -2.10%
Mar 4, 2024
Reiterates: Overweight
Price Target: $382 → $392
Current: $293.64
Upside: +33.50%
Nov 14, 2023
Maintains: Underweight
Price Target: $69 → $65
Current: $74.97
Upside: -13.30%
Nov 2, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $54.55
Upside: +83.32%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $532.51
Upside: +10.23%
Nov 15, 2022
Maintains: Overweight
Price Target: $264 → $248
Current: $168.61
Upside: +47.08%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $246.00
Upside: +21.95%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $22.06
Upside: +90.39%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $245.80
Upside: +17.17%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $164.97
Upside: +113.37%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $5.62
Upside: +682.92%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $344.07
Upside: -47.39%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $97.50
Upside: -82.56%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $39.27
Upside: +208.12%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $574.82
Upside: +0.90%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $13.26
Upside: +163.95%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $200.48
Upside: +2.25%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $17.21
Upside: -36.08%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $204.33
Upside: -23.16%
May 9, 2018
Maintains: Outperform
Price Target: $42 → $38
Current: $22.39
Upside: +69.72%
Nov 20, 2017
Maintains: Underperform
Price Target: $31 → $17
Current: $14.94
Upside: +13.79%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $496.96
Upside: -38.02%